Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice

Platelets are crucial for hemostasis and arterial thrombosis, which may lead to severe cardiovascular diseases (CVDs). Thus, therapeutic agents must be developed to prevent pathological platelet activation. Glabridin, a major bioalkaloid extracted from licorice root, improves metabolic abnormalities...

Full description

Bibliographic Details
Main Authors: Chi-Li Chung, Jui-Hsuan Chen, Wei-Chieh Huang, Joen-Rong Sheu, Chih-Wei Hsia, Thanasekaran Jayakumar, Chih-Hsuan Hsia, Kuan-Rau Chiou, Shaw-Min Hou
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/19/11372
_version_ 1797479044447469568
author Chi-Li Chung
Jui-Hsuan Chen
Wei-Chieh Huang
Joen-Rong Sheu
Chih-Wei Hsia
Thanasekaran Jayakumar
Chih-Hsuan Hsia
Kuan-Rau Chiou
Shaw-Min Hou
author_facet Chi-Li Chung
Jui-Hsuan Chen
Wei-Chieh Huang
Joen-Rong Sheu
Chih-Wei Hsia
Thanasekaran Jayakumar
Chih-Hsuan Hsia
Kuan-Rau Chiou
Shaw-Min Hou
author_sort Chi-Li Chung
collection DOAJ
description Platelets are crucial for hemostasis and arterial thrombosis, which may lead to severe cardiovascular diseases (CVDs). Thus, therapeutic agents must be developed to prevent pathological platelet activation. Glabridin, a major bioalkaloid extracted from licorice root, improves metabolic abnormalities (i.e., obesity and diabetes) and protects against CVDs and neuronal disorders. To the best of our knowledge, no studies have focused on glabridin’s effects on platelet activation. Therefore, we investigated these effects in humans and mice. Glabridin exhibited the highest inhibitory effects on collagen-stimulated platelet aggregation and moderate effects on arachidonic-acid-stimulated activation; however, no effects were observed for any other agonists (e.g., thrombin or U46619). Glabridin evidently reduced P-selectin expression, ATP release, and intracellular Ca<sup>2+</sup> ([Ca<sup>2+</sup>]i) mobilization and thromboxane A<sub>2</sub> formation; it further reduced the activation of phospholipase C (PLC)γ2/protein kinase C (PKC), phosphoinositide 3-kinase (PI3K)/Akt/glycogen synthase kinase-3β (GSK3β), mitogen-activated protein kinase (MAPK), and NF-κB. In mice, glabridin reduced the mortality rate caused by acute pulmonary thromboembolism without altering bleeding time. Thus, glabridin effectively inhibits the PLCγ2/PKC cascade and prevents the activation of the PI3K/Akt/GSK3β and MAPK pathways; this leads to a reduction in [Ca<sup>2+</sup>]i mobilization, which eventually inhibits platelet aggregation. Therefore, glabridin may be a promising therapeutic agent for thromboembolic disorders.
first_indexed 2024-03-09T21:40:15Z
format Article
id doaj.art-7f366bbcd2b5495d9a2a597196c7702d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:40:15Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-7f366bbcd2b5495d9a2a597196c7702d2023-11-23T20:32:01ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123191137210.3390/ijms231911372Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and MiceChi-Li Chung0Jui-Hsuan Chen1Wei-Chieh Huang2Joen-Rong Sheu3Chih-Wei Hsia4Thanasekaran Jayakumar5Chih-Hsuan Hsia6Kuan-Rau Chiou7Shaw-Min Hou8Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, TaiwanDepartment of Ecology and Environmental Sciences, Pondicherry University, Puducherry 605014, IndiaTranslational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, TaiwanDivision of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, TaiwanGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, TaiwanPlatelets are crucial for hemostasis and arterial thrombosis, which may lead to severe cardiovascular diseases (CVDs). Thus, therapeutic agents must be developed to prevent pathological platelet activation. Glabridin, a major bioalkaloid extracted from licorice root, improves metabolic abnormalities (i.e., obesity and diabetes) and protects against CVDs and neuronal disorders. To the best of our knowledge, no studies have focused on glabridin’s effects on platelet activation. Therefore, we investigated these effects in humans and mice. Glabridin exhibited the highest inhibitory effects on collagen-stimulated platelet aggregation and moderate effects on arachidonic-acid-stimulated activation; however, no effects were observed for any other agonists (e.g., thrombin or U46619). Glabridin evidently reduced P-selectin expression, ATP release, and intracellular Ca<sup>2+</sup> ([Ca<sup>2+</sup>]i) mobilization and thromboxane A<sub>2</sub> formation; it further reduced the activation of phospholipase C (PLC)γ2/protein kinase C (PKC), phosphoinositide 3-kinase (PI3K)/Akt/glycogen synthase kinase-3β (GSK3β), mitogen-activated protein kinase (MAPK), and NF-κB. In mice, glabridin reduced the mortality rate caused by acute pulmonary thromboembolism without altering bleeding time. Thus, glabridin effectively inhibits the PLCγ2/PKC cascade and prevents the activation of the PI3K/Akt/GSK3β and MAPK pathways; this leads to a reduction in [Ca<sup>2+</sup>]i mobilization, which eventually inhibits platelet aggregation. Therefore, glabridin may be a promising therapeutic agent for thromboembolic disorders.https://www.mdpi.com/1422-0067/23/19/11372glabridinplateletMAPKmicrovascular thrombosisPI3K/Akt/GSK3βPLCγ2/PKC
spellingShingle Chi-Li Chung
Jui-Hsuan Chen
Wei-Chieh Huang
Joen-Rong Sheu
Chih-Wei Hsia
Thanasekaran Jayakumar
Chih-Hsuan Hsia
Kuan-Rau Chiou
Shaw-Min Hou
Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
International Journal of Molecular Sciences
glabridin
platelet
MAPK
microvascular thrombosis
PI3K/Akt/GSK3β
PLCγ2/PKC
title Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
title_full Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
title_fullStr Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
title_full_unstemmed Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
title_short Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
title_sort glabridin a bioactive flavonoid from licorice effectively inhibits platelet activation in humans and mice
topic glabridin
platelet
MAPK
microvascular thrombosis
PI3K/Akt/GSK3β
PLCγ2/PKC
url https://www.mdpi.com/1422-0067/23/19/11372
work_keys_str_mv AT chilichung glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT juihsuanchen glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT weichiehhuang glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT joenrongsheu glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT chihweihsia glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT thanasekaranjayakumar glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT chihhsuanhsia glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT kuanrauchiou glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice
AT shawminhou glabridinabioactiveflavonoidfromlicoriceeffectivelyinhibitsplateletactivationinhumansandmice